Explore

National MS Society Launches $1 Billion 'Campaign to End MS' to Accelerate Research and Patient Support

National MS Society Launches $1 Billion 'Campaign to End MS' to Accelerate Research and Patient Support

The National MS Society has initiated a $1 billion fundraising effort, dubbed the 'Campaign to End MS,' aimed at accelerating research breakthroughs, expanding access to patient care, and providing support for individuals and families affected by multiple sclerosis (MS). This five-year campaign, launched on October 1st, is described as the most ambitious in the organization's 80-year history. At its launch, a gala in New York City raised over $12 million for MS research. The campaign seeks to help approximately 1 million people in the U.S. living with MS receive earlier diagnoses, access timely treatment, and find necessary support. MS is a neurodegenerative disease where the immune system attacks the brain and spinal cord, leading to symptoms like fatigue, movement issues, vision problems, and cognitive difficulties, for which there is currently no cure.

Northwestern Study Reveals Long-Term Opioid Use Ineffective for Chronic Back Pain, Identifies New Molecular Markers

Northwestern Study Reveals Long-Term Opioid Use Ineffective for Chronic Back Pain, Identifies New Molecular Markers

A new study from Northwestern University indicates that long-term opioid use does not significantly improve pain or functioning in individuals suffering from chronic back pain. The research compared 70 long-term opioid users with 70 similar patients who were not taking opioids. Both groups reported nearly identical pain levels, averaging 5.4 on a 10-point scale, suggesting that years of opioid use did not lead to better pain management. While the opioid group showed slightly worse outcomes in physical function and mental health, their brain anatomy remained largely intact, dispelling fears that long-term opioid ingestion severely damages the brain. However, significant differences were observed in spontaneous brain activity, particularly in the mesocorticolimbic network (involved in reward and motivation) and the prefrontal cortex (supporting decision-making). The study, published in the journal Brain, also identified new molecular markers, including those related to serotonin receptors, which could pave t...

International Conference Addresses Long COVID Mechanisms and Research Challenges

International Conference Addresses Long COVID Mechanisms and Research Challenges

The inaugural conference of the International Society for Long COVID and Post-Acute Infection Syndromes (ISLC-PAIS) recently convened in Amsterdam, bringing together researchers, clinicians, and advocates. The four-day event focused on the broad range of proposed biomedical mechanisms underlying Long COVID, including viral persistence, immunological dysregulation, autoimmunity, neurological disruptions, and vascular damage. Presenters acknowledged that previous clinical trials have yielded disappointing results and emphasized the need for more precisely designed 'mechanistic trials' that target specific pathological pathways. The conference also highlighted the innovative use of electronic wearables and remote monitoring to improve research and accurately track biological events, such as post-exertional malaise (PEM). A new U.S. Department of Defense-funded program, PROBE-PASC, was announced, which will focus on mechanistic trials for Long COVID, with an initial trial testing the monoclonal antibody Pemgar...

Obatala Sciences Establishes First East Coast Operation in Charleston County, South Carolina

Obatala Sciences Establishes First East Coast Operation in Charleston County, South Carolina

Obatala Sciences Establishes First East Coast Operation in Charleston County, South Carolina

Study Identifies Beta-Synuclein as Early Blood Biomarker for Alzheimer's in Down Syndrome Patients

Study Identifies Beta-Synuclein as Early Blood Biomarker for Alzheimer's in Down Syndrome Patients

A new study, published in Alzheimer's & Dementia, has identified beta-synuclein as a promising early blood-based biomarker for Alzheimer's disease in individuals with Down syndrome. Researchers from Sant Pau Research Institute (IR Sant Pau), in collaboration with Martin Luther University and the German Center for Neurodegenerative Diseases, found that beta-synuclein levels begin to rise in people with Down syndrome from their third decade of life, approximately 21 years before the average age of prodromal Alzheimer's diagnosis in the studied cohort. Beta-synuclein, a protein primarily located at presynaptic terminals, provides insights into synaptic dysfunction and degeneration, which are considered early events in Alzheimer's. The study analyzed 131 individuals, including 88 adults with Down syndrome at various disease stages and 43 cognitively healthy controls. Results showed beta-synuclein levels were 1.83 times higher in asymptomatic Down syndrome individuals compared to controls, increasing with disea...

From Hashtags to Stories, Instagram’s Evolution Reshaped Social Media Sharing

From Hashtags to Stories, Instagram’s Evolution Reshaped Social Media Sharing

Instagram has continuously evolved its platform to foster community interaction and diverse content creation, introducing a range of features that ...

Vagus Nerve Stimulation Shows Promise in Myelin Repair for Multiple Sclerosis Patients

Vagus Nerve Stimulation Shows Promise in Myelin Repair for Multiple Sclerosis Patients

Neuroscientist Cristin Welle, PhD, and her team at CU Anschutz have discovered that vagus nerve stimulation (VNS) may promote myelin regrowth in individuals with multiple sclerosis (MS). This research, initially conducted on animal models and subsequently in a small human pilot study, has shown promising results, leading to a phased National Institutes of Health grant to further their work. The studies indicated a notable increase in new oligodendrocytes, which are cells responsible for producing myelin, the protective coating around nerve fibers that is damaged in MS. Furthermore, brain images suggested that the regenerated myelin in animal models was returning to its original locations, a phenomenon referred to as myelin pattern recovery, which is linked to improvements in motor function. This approach draws parallels from the successful application of VNS in stroke rehabilitation, where electrical bursts stimulate brain cell regeneration.

New Study Reveals Universal Brain Activity Patterns Under Anesthesia Across Diverse Species

New Study Reveals Universal Brain Activity Patterns Under Anesthesia Across Diverse Species

A new study published in Nature Neuroscience, led by neuroscientist Andrea Luppi of the University of Oxford, has uncovered a universal mechanism by which general anesthesia affects the brain across a wide range of species. The research compared the neural activity of six vastly different animals—humans, macaques, marmosets, mice, zebrafish, and nematodes (roundworms)—when they were awake versus under general anesthesia. Despite 700 million years of evolution separating these species and the use of different anesthetic drugs, consistent patterns emerged. The study found that under anesthesia, neural activity between brain regions became less coordinated, and brain activity appeared more chaotic over time. This suggests that anesthesia induces a breakdown in the relationship between past and future neural activity, causing predictable patterns of brain activity to fall apart. This common pathway of anesthesia involves the spatiotemporal isolation of local neural activity, where individual circuits lose thei...

Turmeric Compounds Show Promise in Improving Memory for Early Alzheimer's Patients

Turmeric Compounds Show Promise in Improving Memory for Early Alzheimer's Patients

A small observational study conducted in Japan has indicated that a concentrated extract of lesser-known turmeric compounds may improve working memory and reduce estimated brain age in older adults with early Alzheimer's disease. Ten participants, with an average age of about 75, took the turmeric extract daily for four months while awaiting anti-amyloid antibody therapy. The study focused on turmeronol A, turmeronol B, and bisacurone, compounds distinct from the more commonly studied curcumin, which have shown anti-inflammatory properties in laboratory and animal studies. After four months, participants demonstrated measurable improvements in specific cognitive tests, including visual learning and working memory tasks. Their estimated brain age improved from an average of 79.5 to 76.3 years. Scores for attention and repeating number sequences also increased. However, the study noted that overall cognitive exam scores and blood tests for inflammation markers did not show significant changes. The study was ...

What Nathan Gallagher said in final 'Below Deck' episode before arrest

What Nathan Gallagher said in final 'Below Deck' episode before arrest

"Below Deck" star Nathan Gallagher talked about his family's future in his final episode before he was convicted on domestic violence-related charges.

Jannik Sinner to miss the rest of the year due to knee inflammation

Jannik Sinner to miss the rest of the year due to knee inflammation

Top-ranked Jannik Sinner has announced he will be out for the rest of the year as he continues to deal with an injured knee

Cornell University Researchers Discover Mobile Human Gene BC200 with Potential Genomic Impact

Cornell University Researchers Discover Mobile Human Gene BC200 with Potential Genomic Impact

Researchers at Cornell University have identified that the human gene BC200, primarily expressed in neurons, retains the ability to move and integrate into genomes. This discovery was made through the identification of the BC200 genetic element within a poxvirus that infects humans, as reported by ScienceDaily. BC200 originates from a transposon, a mobile DNA element capable of changing its position within the genome. While most transposon-derived elements in the human genome are no longer active, BC200 appears to combine a cellular function with mobility. This gene is found exclusively in humans and closely related primates and was initially discovered in the late 1980s as an abundant non-coding RNA in human neurons. Its precise physiological role is still under investigation, but data suggest it may influence the translation of messenger RNAs into proteins in nerve cells.